Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry

by Werner Poewe, Lars Bergmann, Weining Z. Robieson, Angelo Antonini
Published 2020-06-01

Major Adverse Kidney Events Are Associated with the Aquaporin 5 -1364A/C Promoter Polymorphism in Sepsis: A Prospective Validation Study

by Lars Bergmann, Hartmuth Nowak, Winfried Siffert, Jürgen Peters, Michael Adamzik, Björn Koos, Tim Rahmel
Published 2020-04-01

EFFICACY, SAFETY AND PATIENT’S QUALITY OF LIFE OF LONG-TERM TREATMENT WITH LEVODOPA-CARBIDOPA INTESTINAL GEL IN ADVANCED PARKINSON’S DISEASE IN ROMANIA: RESULTS FROM GLORIA OBSERVA...

by Jozsef SZASZ, Mihaela SIMU, Lacramioara PERJU-DUMBRAVA, Angelo ANTONINI, Lars BERGMANN, Diana POPESCU, Ovidiu Alexandru BAJENARU
Published 2020-03-01

The Aquaporin 5 −1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients

by Tim Rahmel, Hartmuth Nowak, Katharina Rump, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Published 2019-12-01

Corrigendum: The Aquaporin 5 −1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients

by Tim Rahmel, Hartmuth Nowak, Sandra Frisenda, Katharina Rump, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Published 2021-08-01

Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare.

by Tim Rahmel, Stefanie Schmitz, Hartmuth Nowak, Kaspar Schepanek, Lars Bergmann, Peter Halberstadt, Stefan Hörter, Jürgen Peters, Michael Adamzik
Published 2020-01-01

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa

by Cindy Zadikoff, Werner Poewe, James T. Boyd, Lars Bergmann, Horia Ijacu, Pavnit Kukreja, Weining Z. Robieson, Janet Benesh, Angelo Antonini
Published 2020-01-01

A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes.

by Caroline Holtkamp, Björn Koos, Matthias Unterberg, Tim Rahmel, Lars Bergmann, Zainab Bazzi, Maha Bazzi, Hassan Bukhari, Michael Adamzik, Katharina Rump
Published 2019-01-01

The <em>NFKB1</em> Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications o...

by Hartmuth Nowak, Svenja Vornweg, Katharina Rump, Tim Rahmel, Matthias Unterberg, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Published 2021-02-01

The Aquaporin3 Promoter Polymorphism −1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell Migration

by Katharina Rump, Tim Rahmel, Anna-Maria Rustige, Matthias Unterberg, Hartmuth Nowak, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Published 2020-06-01

AQP5-1364A/C polymorphism and the AQP5 expression influence sepsis survival and immune cell migration: a prospective laboratory and patient study

by Katharina Rump, Matthias Unterberg, Lars Bergmann, Agnes Bankfalvi, Anil Menon, Simon Schäfer, André Scherag, Zainab Bazzi, Winfried Siffert, Jürgen Peters, Michael Adamzik
Published 2016-11-01

Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients

by Alfonso Fasano, Victor S. C. Fung, Leonardo Lopiano, Bulent Elibol, Irina G. Smolentseva, Klaus Seppi, Annamária Takáts, Koray Onuk, Juan Carlos Parra, Lars Bergmann, Kavita Sail, Yash Jalundhwala, Zvezdan Pirtosek
Published 2019-04-01